In May, President Trump signed an executive order imposing Most-Favored-Nation (MFN) price caps on pharmaceuticals. While the problems of price caps like MFN pricing have been explored at length, the order had an upside in that it also included a provision to facilitate the direct sale of prescriptions to patients for manufacturers that meet the price cap. Direct-to-consumer (DTC) sales can help lower prices for patients.
Read Full Article »
